← Open Payments lookup

WESLEY BOYD: Open Payments

NPI 1386097921 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,009 in 122 payments from 22 companies in 2025. Trend: 2023 $1,544 · 2024 $1,911 · 2025 $2,009

Food & beverage: $2,009
CompanyPaymentsAmount
ABBVIE INC.42$540
Takeda Pharmaceuticals U.S.A., Inc.11$219
Aimmune Therapeutics, Inc.8$153
PFIZER INC.8$138
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$119
Janssen Biotech, Inc.5$101
Regeneron Healthcare Solutions, Inc.3$84
QOL Medical, LLC4$82
Lilly USA, LLC5$81
Madrigal Pharmaceuticals3$71

Products named: RINVOQ, ENTYVIO, DUPIXENT, LINZESS, VELSIPITY, XIFAXAN, TREMFYA, VOWST.

Industry payments across MS — which companies pay providers there.